The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections-Reference-Cited by-同舟云学术

The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections

Published:2020-01 Issue:1 Volume:30 Page:112-123.e4
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Katsuyama Eri,Suarez-Fueyo Abel^ORCID,Bradley Sean J.,Mizui Masayuki,Marin Ana V.,Mulki Lama,Krishfield Suzanne,Malavasi Fabio,Yoon Joon,Sui Shannan J. Ho,Kyttaris Vasileios C.,Tsokos George C.

Funder

National Institutes of Health

NIH

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference84 articles.

1. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP;Aarhus;J. Biol. Chem.,1995

2. Regulation of intracellular levels of NAD: a novel role for CD38;Aksoy;Biochem. Biophys. Res. Commun.,2006

3. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2;Alcocer-Varela;J. Autoimmun.,1991

4. FastQC: a quality control tool for high throughput sequence data. Available online;Andrews,2010

5. Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens;Arbuckle;MBio,2017

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic control of immunopathogenesis in systemic lupus erythematosus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. T cells;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. Expanded CD8⁺CD38⁺ T Cell Population in Patients With Systemic Lupus Erythematosus Is Linked to Increased Infection Rates: A Prospective Study;ACR Open Rheumatology;2024-08-30

4. The immunology of systemic lupus erythematosus;Nature Immunology;2024-07-15

5. High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance;Communications Medicine;2024-07-02